Can low aldosterone cause sodium loss, lower blood volume, and orthostatic symptoms?

Aldosterone is a key steroid hormone produced by the adrenal glands that serves as a primary regulator of the body’s sodium and water balance. In the context of orthostatic symptoms—such as dizziness, lightheadedness, or fainting upon standing—low levels of aldosterone can create a physiological cascade that compromises the body's ability to maintain stable blood pressure during postural changes.

Clinical and mechanistic evidence

The link between aldosterone deficiency and orthostatic instability is rooted in renal physiology and fluid dynamics:

• Renal Sodium Wasting: Aldosterone normally binds to mineralocorticoid receptors (MR) in the distal tubules and collecting ducts of the kidney. This process triggers the insertion of epithelial sodium channels (ENaC) into the cell membrane, allowing the body to reabsorb sodium from the urine. When aldosterone is low, this mechanism fails, leading to excessive sodium loss (natriuresis).
• Intravascular Volume Depletion: Because water follows sodium osmotically, the failure to retain sodium leads to increased water excretion (diuresis). Research using radioisotope dilution techniques has confirmed that these states result in a measurable reduction in plasma and overall blood volume (hypovolemia).
• Postural Blood Pressure Failure: Adequate blood volume is essential for the "venous return" required to maintain cardiac output when a person stands. In a hypovolemic state caused by low aldosterone, the gravitational shift of blood to the lower extremities is not adequately compensated for, leading to a drop in blood pressure (orthostatic hypotension) and subsequent symptoms like dizziness or syncope.

Implications for older adults

For a 71-year-old female, the impact of low aldosterone may be more pronounced due to age-related physiological shifts:

• Baroreflex Sensitivity: Older adults often experience reduced baroreflex sensitivity, meaning the body is slower to adjust heart rate and vascular tone when blood pressure drops. When combined with low blood volume, this significantly increases the risk of symptomatic orthostatic hypotension.
• Renal Aging: The aging kidney may already have a reduced capacity to conserve sodium, making the loss of aldosterone-mediated reabsorption particularly impactful.
• Clinical Management: The efficacy of fludrocortisone—a synthetic mineralocorticoid used to treat orthostatic hypotension—further validates this mechanism, as it works by mimicking aldosterone to expand blood volume.

Bottom line

Low aldosterone directly causes renal sodium wasting and subsequent volume depletion. This reduction in blood volume impairs the body’s ability to maintain blood pressure upon standing, leading to orthostatic symptoms. In older individuals, this effect is often exacerbated by reduced baroreflex sensitivity and age-related renal changes.